Back to Trades
Sell4
TEXAS INSTRUMENTS INC
TXN
Total Value
$1.6M
Net $696.6K sold
Sales
$696.6K
1 transaction
Company Information
- Company Name
- TEXAS INSTRUMENTS INC
- Ticker Symbol
- TXN
- CIK
- 0000097476
Insider Information
- Name
- BLINN MARK A
- Role
- Director
- Location
- DALLAS, TX
Director
Filing Details
- Filing Date
- Feb 6, 2026
- Transaction Date
- Feb 5, 2026
- Accession Number
- 0000097476-26-000063
- Form Type
- 4
- Net Trading Amount
- -$696.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 5, 2026 | Common Stock | 628 | $174.81 | Exercise | $109.8K |
| Feb 5, 2026 | Common Stock | 540 | $174.10 | Exercise | $94.0K |
| Feb 5, 2026 | Common Stock | 767 | $167.42 | Exercise | $128.4K |
| Feb 5, 2026 | Common Stock | 637 | $187.03 | Exercise | $119.1K |
| Feb 5, 2026 | Common Stock | 3,144 | $221.58 | Sale | $696.6K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 5, 2026 | Derivative | 628 | $174.81 | Exercise | $109.8K |
| Feb 5, 2026 | Derivative | 540 | $174.10 | Exercise | $94.0K |
| Feb 5, 2026 | Derivative | 767 | $167.42 | Exercise | $128.4K |
| Feb 5, 2026 | Derivative | 637 | $187.03 | Exercise | $119.1K |
Footnotes
- (F1)The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $221.00 to $221.93. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
- (F2)Shares held in Trust for the benefit of family member; reporting person shares investment control. Beneficial ownership by reporting person disclaimed.
- (F3)Shares held in Trust for the benefit of family member of which reporting person is trustee. Beneficial ownership by reporting person disclaimed.
- (F4)Shares held in Trust for the benefit of the reporting person. Reporting person is the sole trustee.
- (F5)The option became exercisable in four equal annual installments beginning on January 27, 2023.
- (F6)The option became exercisable in four equal annual installments beginning on January 26, 2024.
- (F7)The option became exercisable in four equal annual installments beginning on January 25, 2025.
- (F8)The option became exercisable in four equal annual installments beginning on January 27, 2026.